Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanda Aryal

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BMJ Quality & Safety|March 13, 2026
Is independent double-checking superior to single-checking in medication administration error detection? A randomised controlled simulation trialJohanna I Westbrook, Ryan Daniel McMullan, Erin Fitzpatrick, et al.
Internal Medicine Journal|November 24, 2023
No relationship between socioeconomic status, education level and development and progression of diabetic retinopathy in type 2 diabetes: a FIELD trial substudyBen Rao, Andrzej S Januszewski, Laima Brazionis, et al.
Diabetes Research and Clinical Practice|January 7, 2023
Corrigendum to "Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy" [Diab. Res. Clin. Pract. 186 (2022) 109835]Benjamin N Rao, Nicola Quinn, Andrzej S Januszewski, et al.
Diabetes Research and Clinical Practice|March 22, 2022
Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudyBenjamin N Rao, Nicola Quinn, Andrzej S Januszewski, et al.
Diabetes, Obesity & Metabolism|April 4, 2020
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD studyJacob Y Cao, Boris Waldman, Rachel O'Connell, et al.
Drug Safety|March 13, 2024
Drug-Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System ImplementationLing Li, Jannah Baker, Renee Quirk, et al.
Gynecologic Oncology|February 4, 2022
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 studyFabian Trillsch, Sven Mahner, Beyhan Ataseven, et al.
BMJ Quality & Safety|May 11, 2025
Effectiveness of computerised alerts to reduce drug-drug interactions (DDIs) and DDI-related harm in hospitalised patients: a quasi-experimental controlled pre-post studyMelissa Therese Baysari, Sarah Nicole Hilmer, Richard O Day, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BMJ Quality & Safety|March 13, 2026
Is independent double-checking superior to single-checking in medication administration error detection? A randomised controlled simulation trialJohanna I Westbrook, Ryan Daniel McMullan, Erin Fitzpatrick, et al.
Internal Medicine Journal|November 24, 2023
No relationship between socioeconomic status, education level and development and progression of diabetic retinopathy in type 2 diabetes: a FIELD trial substudyBen Rao, Andrzej S Januszewski, Laima Brazionis, et al.
Diabetes Research and Clinical Practice|January 7, 2023
Corrigendum to "Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy" [Diab. Res. Clin. Pract. 186 (2022) 109835]Benjamin N Rao, Nicola Quinn, Andrzej S Januszewski, et al.
Diabetes Research and Clinical Practice|March 22, 2022
Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudyBenjamin N Rao, Nicola Quinn, Andrzej S Januszewski, et al.
Diabetes, Obesity & Metabolism|April 4, 2020
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD studyJacob Y Cao, Boris Waldman, Rachel O'Connell, et al.
Drug Safety|March 13, 2024
Drug-Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System ImplementationLing Li, Jannah Baker, Renee Quirk, et al.
Gynecologic Oncology|February 4, 2022
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 studyFabian Trillsch, Sven Mahner, Beyhan Ataseven, et al.
BMJ Quality & Safety|May 11, 2025
Effectiveness of computerised alerts to reduce drug-drug interactions (DDIs) and DDI-related harm in hospitalised patients: a quasi-experimental controlled pre-post studyMelissa Therese Baysari, Sarah Nicole Hilmer, Richard O Day, et al.
Pageof 2